For example, our pathway and transcriptional regulator analyses highlighted the importance of AMPK, PGC-1α, PPARα, ERRα, and ERRγ in regulating metabolic reprogramming in ADPKD. This evidence concerns the gene PPARGC1A and autosomal dominant polycystic kidney disease.